AC
LLY icon

Arrow Capital’s Eli Lilly LLY Stock Holding History

Arrow Capital’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-6,594
Closed -$7.85M – 36
2025
Q2 		$7.85M Buy
6,594
+94
+1% +$73K 3.8% 11
2025
Q1 		$5.6M Sell
6,500
-2,000
-24% -$1.66M 7% 6
2024
Q4 		$6.56M Buy
+8,500
New +$7.04M 6.01% 2

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Arrow Capital's LLY Position: Q3 2025 in Review

Arrow Capital sold out of Eli Lilly (LLY) in Q3 2025, closing a stake of 6,594 shares — an estimated $7.85M sold.

Arrow Capital first reported a position in LLY in Q4 2024 and held it in 3 quarters. The position peaked at $7.85M in Q2 2025. 3,897 funds tracked by Wall St. Rank hold LLY as of Q3 2025.

  • Arrow Capital reported no remaining Eli Lilly position as of Q3 2025 after selling out during the quarter.
  • Arrow Capital sold 6,594 Eli Lilly shares in Q3 2025, an estimated $7.85M.
  • Arrow Capital first reported a position in Eli Lilly in Q4 2024 and held it in 3 quarters.
  • Arrow Capital's Eli Lilly position peaked at $7.85M in Q2 2025.
  • 3,897 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2025.

Based on Arrow Capital's 13F filing for Q3 2025, filed 14 Nov 2025.